GeminIQ

BMY

BRISTOL MYERS SQUIBB CO
—

Company Information

Company Name
BRISTOL MYERS SQUIBB CO
CIK
CIK0000014272
Category
Large accelerated filer
Ticker: Exchange
BMY: NYSE, CELG-RI: NYSE
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
BMY

SEC filing data through

Insider Sentiment

Last purchase
2025-04-25
Last sale
2026-09-09
Shares purchased (TTM)
0
Shares sold (TTM)
36,749
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
1,641,699,756
Shares outstanding
2,042,000,000
Ownership
80.40%
+3.40% Y/Y

Earnings Market Reaction

Filing date
2026-07-30
Price on filing date
—
1-month reaction
3.31%
3-month reaction
Pending
Drift continued2/11 (18%)
Faded / reversed9/11 (82%)
Export data

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value8,7229,57410,20915,72612,59910,87510,3467,8906,2939,33011,4647,514
Marketable Securities Current-----------171
Available For Sale Securities Debt Securities Current2,3459124647761,004907513204360340816-
Receivables Net Current10,5539,36811,41411,42211,41510,80110,74711,02611,42310,44710,92110,304
Assets Current
Assets Current28,57927,20829,39035,63033,22230,78329,78028,07526,89028,66931,77027,632
Inventory Net2,7372,7562,6902,7582,7372,6662,5573,3323,0772,9852,6622,436
Other Assets Current4,2224,5974,6134,9485,4665,5345,6175,6235,7375,5675,9077,207
Property Plant And Equipment Net7,7917,6587,5437,3497,3737,2137,1366,9036,8456,7506,6466,481
Goodwill21,74021,74021,75421,74521,77621,73721,71921,75121,73221,73821,16921,147
Intangible Assets Net Excluding Goodwill17,38718,24419,10320,46521,37822,48623,30726,96429,42832,76027,07228,950
Deferred Income Tax Assets Net5,3625,1765,3784,9614,6473,9974,2363,6093,3232,7232,7681,514
Marketable Securities-----------325
Available For Sale Securities Debt Securities Noncurrent397366396406346344320324357367364-
Other Assets Noncurrent6,3786,0826,4746,3325,9365,8666,1056,0446,0716,0245,3705,214
Assets87,63486,47690,03896,88994,67692,42792,60393,67094,64699,03195,15991,263
Liabilities
Debt Current1,0272,3082,2614,5094,7153,5542,0461,0783,5316,1903,1195,467
Accounts Payable Current4,1584,2343,5754,2885,4274,0023,6023,4693,7513,5393,2592,813
Liabilities Current
Liabilities Current18,65919,15823,41728,13627,52824,07023,77422,63823,26525,82222,26223,462
Other Liabilities Current13,47412,61617,58119,33917,38616,51418,12618,09115,98316,09315,88415,182
Deferred Income Tax Liabilities Net222211222225247276369430461442338399
Long Term Debt Noncurrent42,09342,15242,85044,46944,47046,15747,60348,67448,85849,48736,65332,137
Other Liabilities Noncurrent4,3414,8535,0435,4594,9424,4774,4694,7284,9936,7326,4216,203
Liabilities65,31566,37471,53378,28977,18774,97976,21576,47077,57782,48365,67462,201
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
Preferred Stock Value000000000000
Common Stock Value Outstanding292292292292292292292292292292292292
Additional Paid In Capital46,50446,37446,38746,26546,13446,01146,02445,89645,76645,65545,68444,849
Stockholders Equity
Stockholders Equity22,31920,06818,47318,60017,48917,44816,33517,14217,06916,49029,43029,062
Accumulated Other Comprehensive Income Loss Net Of Tax-1,290-1,370-1,524-1,513-1,554-1,424-1,238-1,468-1,456-1,400-1,546-1,286
Retained Earnings Accumulated Deficit20,31618,28716,89617,09316,15416,10614,91216,09716,10315,64028,76628,218
Treasury Stock Common Value-43,504-43,515-43,579-43,586-43,590-43,597-43,655-43,675-43,690-43,697-43,766-43,075
Minority Interest03433485459535854585564
Liabilities And Stockholders Equity87,63486,47690,03896,88994,67692,42792,60393,67094,64699,03195,15991,263
Preferred Stock Dividend Rate Per Dollar Amount--0---0---0-
Preferred Stock Par Or Stated Value Per Share--1.00---1.00---1.00-
Preferred Stock Shares Authorized--10---10---10-
Preferred Stock Shares Issued--0---0---0-
Preferred Stock Shares Outstanding--0---0---0-
Preferred Stock Liquidation Preference Value--50---50---50-
Common Stock Par Or Stated Value Per Share--0.10---0.10---0.10-
Common Stock Shares Authorized--4,500---4,500---4,500-
Common Stock Shares Issued--2,900---2,900---2,900-
Treasury Stock Common Shares--887---894---902-

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

BRISTOL MYERS SQUIBB CO (BMY) — SEC Financial Statements & Analysis

BRISTOL MYERS SQUIBB CO (BMY) is a pharmaceutical preparations company, incorporated in DE. BRISTOL MYERS SQUIBB CO trades on NYSE as: BMY, CELG-RI. BRISTOL MYERS SQUIBB CO (BMY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, BRISTOL MYERS SQUIBB CO carries a market cap of $116.35B, a P/E ratio of 12.54x, a P/B ratio of 5.21x, a P/S ratio of 2.37x, an enterprise value of $150.74B, and an EV/EBITDA multiple of 9.99x. On profitability, it posts a gross margin of 70.16%, an operating margin of 24.21%, a net margin of 18.87%, a Return on Equity (ROE) of 46.62%, a Return on Assets (ROA) of 10.18%, and a Return on Invested Capital (ROIC) of 16.46%. Per share, it reports EPS of $4.54, diluted EPS of $4.53, free cash flow per share of $5.60, and a dividend per share of $2.50. Over the trailing year, it posted revenue growth of 3.11% year-over-year, net income growth of 83.29% year-over-year, and EPS growth of 82.66% year-over-year. On the balance sheet, it maintains a current ratio of 1.53x, a quick ratio of 1.38x, working capital of $9.92B, a debt-to-equity ratio of 2.93x, a debt ratio of 0.75, free cash flow of $11.44B (TTM), and net debt of $34.40B. Figures sourced from SEC EDGAR.

Market Cap
$116.35B
P/E TTM
12.54x
EPS TTM
$4.54
P/B TTM
5.21x
ROE TTM
46.62%
ROA TTM
10.18%
Debt To Equity
2.93x
Free Cash Flow TTM
$11.44B
Net Revenue TTM Growth 1Y
3.11%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BRISTOL MYERS SQUIBB CO in?

BRISTOL MYERS SQUIBB CO (BMY) operates in the Pharmaceutical Preparations industry.

What exchange does BMY trade on?

BRISTOL MYERS SQUIBB CO (BMY) trades on the NYSE.

Where is BRISTOL MYERS SQUIBB CO incorporated?

BRISTOL MYERS SQUIBB CO is incorporated in DE.

When was BRISTOL MYERS SQUIBB CO (BMY)'s most recent SEC filing?

BRISTOL MYERS SQUIBB CO (BMY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.

What is BMY's market cap?

BRISTOL MYERS SQUIBB CO (BMY) has a market capitalization of $116.35B as of 2026-06-30.

What is BMY's P/E ratio?

BRISTOL MYERS SQUIBB CO (BMY)'s trailing twelve month P/E ratio is 12.54x as of 2026-06-30.

What is BMY's EPS (earnings per share)?

BRISTOL MYERS SQUIBB CO (BMY)'s trailing twelve month EPS is $4.54 as of 2026-06-30.

What is BMY's ROE (return on equity)?

BRISTOL MYERS SQUIBB CO (BMY)'s trailing twelve month Return on Equity (ROE) is 46.62% as of 2026-06-30.

What is BMY's ROA (return on assets)?

BRISTOL MYERS SQUIBB CO (BMY)'s trailing twelve month Return on Assets (ROA) is 10.18% as of 2026-06-30.

What is BMY's ROIC (return on invested capital)?

BRISTOL MYERS SQUIBB CO (BMY)'s trailing twelve month Return on Invested Capital (ROIC) is 16.46% as of 2026-06-30.

What is BMY's EV/EBITDA?

BRISTOL MYERS SQUIBB CO (BMY)'s trailing twelve month EV/EBITDA is 9.99x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial